| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 225 | 334 | 13.179 | 0 | 316 | 310 | 0 | 3.001 | 0 | 0 |
| Total Income - EUR | 225 | 334 | 13.179 | 267 | 629 | 310 | 0 | 10.589 | 515 | 0 |
| Total Expenses - EUR | 117 | 8 | 0 | 281 | 101 | 35 | 0 | 8.352 | 22 | 24 |
| Gross Profit/Loss - EUR | 108 | 326 | 13.179 | -14 | 528 | 275 | 0 | 2.237 | 493 | -24 |
| Net Profit/Loss - EUR | 101 | 316 | 12.783 | -22 | 509 | 266 | 0 | 1.984 | 416 | -24 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Proctocenter Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 8.907 | 8.756 | 8.596 | 8.429 | 8.269 | 8.086 | 0 | 0 | 0 |
| Current Assets | 276 | 58 | 13.017 | 12.962 | 13.229 | 12.710 | 12.428 | 12.375 | 4.301 | 4.178 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 225 | 0 | 12.960 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| Cash | 51 | 58 | 57 | 12.962 | 13.229 | 12.709 | 12.427 | 12.375 | 4.301 | 4.177 |
| Shareholders Funds | 146 | 460 | 13.236 | 12.971 | 13.229 | 13.244 | 12.950 | 3.821 | 4.226 | 4.178 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 130 | 8.505 | 8.538 | 8.586 | 8.429 | 7.736 | 7.564 | 8.553 | 76 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Proctocenter Srl